ASVRX
Price
$9.13
Change
-$0.05 (-0.54%)
Updated
May 22 closing price
Net Assets
4.56B
PEVAX
Price
$15.05
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
N/A
Interact to see
Advertisement

ASVRX vs PEVAX

Header iconASVRX vs PEVAX Comparison
Open Charts ASVRX vs PEVAXBanner chart's image
American Century Small Cap Value R
Price$9.13
Change-$0.05 (-0.54%)
VolumeN/A
Net Assets4.56B
PACE Small/Medium Co Value Equity A
Price$15.05
Change-$0.00 (-0.00%)
VolumeN/A
Net AssetsN/A
ASVRX vs PEVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASVRX vs. PEVAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Buy and PEVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEVAX pays higher dividends than ASVRX: PEVAX (0.77) vs ASVRX (0.54). ASVRX was incepted earlier than PEVAX: ASVRX (15 years) vs PEVAX (25 years). ASVRX (1.59) is less costly to investors than PEVAX (1.29). PEVAX is a more actively managed with annual turnover of: 119.00 vs. ASVRX (46.00). PEVAX has a lower initial minimum investment than ASVRX: PEVAX (1000) vs ASVRX (2500). ASVRX annual gain was more profitable for investors over the last year : -8.59 vs. PEVAX (-17.58). ASVRX return over 5 years is better than : 70.42 vs. PEVAX (5.39).
ASVRXPEVAXASVRX / PEVAX
Total Expense Ratio1.591.29123%
Annual Report Gross Expense Ratio1.591.29123%
Fund Existence15 years25 years-
Gain YTD-6.706-4.908137%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets4.56BN/A-
Annual Yield % from dividends0.540.7771%
Returns for 1 year-8.59-17.5849%
Returns for 3 years3.27-21.79-15%
Returns for 5 years70.425.391,307%
Returns for 10 years5.78-23.03-25%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLCX72.77N/A
N/A
Rydex Leisure C
LEGCX48.91N/A
N/A
Columbia Large Cap Growth C
MNBAX19.75N/A
N/A
Manning & Napier Pro-Blend Extnd Term S
PMVFX24.75N/A
N/A
PGIM Quant Solutions Mid-Cap Val R4
MVISX41.00N/A
N/A
Patient Opportunity IS